Orchid Pharma Limited

Kotak Mutual Fund increased its stake in Orchid Pharma from 4.31% to 4.60%, acquiring an additional 149,136 shares. The value of the additional shares is ₹14.88 Cr at a price of ₹998.35 apiece.

A pharmaceutical manufacturer focused on active pharmaceutical ingredients and finished dosage forms, Orchid Pharma develops and produces medicines for domestic and international markets. The company operates across API manufacturing, formulation development, and new drug research, serving healthcare providers and patients through a vertically integrated approach. Its distinctive strength lies in combining chemical synthesis capabilities with drug discovery efforts to deliver therapeutic solutions across multiple therapeutic areas.

Wholly owned subsidiary of Kotak Mahindra Bank, one of India's leading private banks. Manages over Rs 4.5 lakh crore in AUM. MD Nilesh Shah is a fixture in Indian financial media and one of the most quoted fund managers in the country. Known for disciplined quality growth positioning and clear communication of investment rationale to investors.